dpp 4 inhibitor and glp 1 agonist The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect GLP-1 Receptor Agonists Have better

Sensitivity analysis The estimates from sensitivity analyses are summarized in Supplementary Figs

Curbing the appetites and restoring the capacity for satisfaction: the impact of GLP-1 agonists on the reward circuitry

J., Dmarco, L., Castelao, A

After 82 wk of treatment of T2DM patients with exenatide, the placebo-subtracted weight loss from baseline is approximately 5% [886]

3.0%6.6% and 0.4% of patients in the respective groups discontinued treatment because of these adverse events (54)

SAR441255 demonstrated superior weight loss compared to dual GLP-1/GCG agonists in animal models and did not exhibit major cardiovascular adverse effects in lean monkeys